In January 2025, Haleon announced a $54.2 million investment , to modernize and expand its Richmond research and development facility. The project will support the adoption of innovative technologies, strengthen research capabilities, and reinforce Richmond's position as a growing life sciences and pharmaceutical hub.

As part of the expansion, Haleon partnered with the Commonwealth of Virginia and Virginia Commonwealth University to launch the Haleon-Commonwealth Consumer Healthcare Internship Program for Advanced Life Sciences. The five-year initiative will provide paid internship opportunities for undergraduate and graduate students, helping develop the next generation of life sciences talent in Virginia.

Lisa Paley, Haleon's North America President, described the investment as both a commitment to innovation and to the Richmond community, noting that the modernization supports the company's mission of delivering "everyday health with humanity" while helping build Richmond's future workforce.